RIGL logo
Rigel Pharmaceuticals, Inc.(RIGL)
Closing price · checked 12:44 AM EDTAbout this dataData status
$46.72▲0.75 (1.63%)Earnings · Nov 3
Extended:$46.72+0.00 (+0.00%)

RIGL Market Cap

$872.72MCurrent · USD

Retrieved:

RIGL Market Cap
RIGL Market Cap$20.58B-$2.07B
2000-12-012026-10-20

Source: Stock Alarm market data pipeline (FMP). Daily history. Dates identify market observations.

RIGL market cap history

Total market capitalization. The available daily history series contains 2460 observations from Dec 1, 2000 to Oct 20, 2026.

Rigel Pharmaceuticals Inc Market Cap — Daily history
DateMarket Cap
872,723,199
872,723,199
858,713,302
882,623,526
874,591,185
880,568,741
911,764,113
918,005,055
923,906,024
874,591,185
896,446,625
861,328,483
892,710,652
880,755,540
877,393,165
899,435,403
913,258,502
922,038,037
899,995,799
894,578,639
899,061,806
897,847,615
879,634,748
867,306,039
856,471,718
830,880,306
828,638,722
847,131,787
882,436,728
883,183,922
882,063,130
884,865,110
909,148,932
905,973,355
923,158,829
887,293,492
862,636,073
864,877,657
874,253,080
868,240,032
873,283,595
842,648,620
857,218,913
845,263,800
877,206,366
814,815,624
792,960,184
795,388,566
761,951,611
785,942,159
784,927,843
778,203,092
750,370,096
732,624,227
756,160,854
722,910,698
699,187,272
687,605,757
729,822,247
719,174,725
698,440,077
686,298,166
687,792,555
706,098,821
734,305,414
741,030,165
757,281,646
778,389,891
778,389,891
769,236,758
769,049,959
771,478,342
794,828,170
817,430,805
801,926,518
795,014,969
751,957,885
723,284,295
715,251,954
730,756,240
730,756,240
722,723,899
690,968,132
690,968,132
682,748,992
665,189,921
667,431,505
614,754,291
623,347,028
623,347,028
606,348,353
624,281,021
613,633,499
599,250,005
577,394,565
573,845,391
561,890,279
559,088,299
565,065,856
565,999,849

Compare market cap

Other companies in Health Care. Each page shows its own reporting periods and currency.

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.